Correlation Between Genovis AB and Stayble Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovis AB and Stayble Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovis AB and Stayble Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovis AB and Stayble Therapeutics AB, you can compare the effects of market volatilities on Genovis AB and Stayble Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovis AB with a short position of Stayble Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovis AB and Stayble Therapeutics.

Diversification Opportunities for Genovis AB and Stayble Therapeutics

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Genovis and Stayble is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Genovis AB and Stayble Therapeutics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stayble Therapeutics and Genovis AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovis AB are associated (or correlated) with Stayble Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stayble Therapeutics has no effect on the direction of Genovis AB i.e., Genovis AB and Stayble Therapeutics go up and down completely randomly.

Pair Corralation between Genovis AB and Stayble Therapeutics

Assuming the 90 days trading horizon Genovis AB is expected to generate 1.11 times more return on investment than Stayble Therapeutics. However, Genovis AB is 1.11 times more volatile than Stayble Therapeutics AB. It trades about 0.16 of its potential returns per unit of risk. Stayble Therapeutics AB is currently generating about -0.14 per unit of risk. If you would invest  2,175  in Genovis AB on September 1, 2024 and sell it today you would earn a total of  450.00  from holding Genovis AB or generate 20.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Genovis AB  vs.  Stayble Therapeutics AB

 Performance 
       Timeline  
Genovis AB 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Genovis AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Genovis AB may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Stayble Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stayble Therapeutics AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Genovis AB and Stayble Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovis AB and Stayble Therapeutics

The main advantage of trading using opposite Genovis AB and Stayble Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovis AB position performs unexpectedly, Stayble Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stayble Therapeutics will offset losses from the drop in Stayble Therapeutics' long position.
The idea behind Genovis AB and Stayble Therapeutics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Managers
Screen money managers from public funds and ETFs managed around the world